Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
株式のランク #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
株価
$38.41
時価総額
$170.67B
変化(1日)
1.17%
変化(1年)
-49.92%
DK
取引 Novo Nordisk A/S (NVO)

カテゴリー

Novo Nordisk A/S(NVO)の配当履歴
Novo Nordisk A/S(証券コード:NVO)は合計で28回の配当を行いました。
すべての配当の合計(株式分割調整済み)は:$59.48
配当利回り(TTM):0.0375
2002から2026までのNovo Nordisk A/S(NVO)の配当履歴
年間配当支払い
配当(株式分割調整済み) 変化
2026 (TTM) $0.5862 -66.10%
2025 $1.73 19.34%
2024 $1.45 40.61%
2023 $1.03 28.11%
2022 $0.8044 8.63%
2021 $0.7405 13.28%
2020 $0.6537 6.12%
2019 $0.616 -2.22%
2018 $0.63 10.53%
2017 $0.57 -19.55%
2016 $0.7085 98.18%
2015 $0.3575 -13.96%
2014 $0.4155 -97.69%
2013 $18.00 28.57%
2012 $14.00 40.00%
2011 $10.00 33.33%
2010 $7.50 6,718.18%
2009 $0.11 -34.33%
2002 $0.1675 0.00%
すべての配当支払いの一覧
配当 変化
2026 (TTM) $0.5862 -66.10%
2025 $1.73 19.75%
2024 $1.44 -29.65%
2023 $2.05 27.91%
2022 $1.60 8.26%
2021 $1.48 13.22%
2020 $1.31 6.89%
2019 $1.22 -3.09%
2018 $1.26 10.63%
2017 $1.14 -19.40%
2016 $1.42 95.85%
2015 $0.7236 -12.90%
2014 $0.8308 -73.39%
2013 $3.12 25.69%
2012 $2.48 30.47%
2011 $1.90 41.59%
2010 $1.34 22.30%
2009 $1.10 -67.18%
2002 $3.35 0.00%
同業他社や競合企業の配当履歴